Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI

NMR in Biomedicine

Volumn 12, Issue 3, 1999, Pages 123-138

  Nelson, Sarah J ^a   Vigneron, Daniel B ^a   Dillon, William P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain tumors; MR spectroscopy; Radiotherapy; Treatment response

Indexed keywords

BRACHYTHERAPY; BRAIN TUMOR; CANCER CHEMOTHERAPY; DATA ANALYSIS; DIFFERENTIAL DIAGNOSIS; DRUG RESPONSE; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT CARE; PRIORITY JOURNAL; RADIOSURGERY; REVIEW; TREATMENT PLANNING; TUMOR GROWTH; TUMOR RECURRENCE;

ANIMALS; ASTROCYTOMA; BLOOD VOLUME; BRACHYTHERAPY; BRAIN; BRAIN NEOPLASMS; CONTRAST MEDIA; FLUORODEOXYGLUCOSE F18; GADOLINIUM; GLIOMA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; RADIOSURGERY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033001398     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(199905)12:3<123::AID-NBM541>3.0.CO;2-Y     Document Type: Review

References (119)

1. Arnold D. L., Shoubridge E. A., Villemure J. G. and Feindel W. Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading. NMR. Biomed. 3, 184-189 (1990).
2. Glickson J. D. Clinical NMR spectroscopy of tumors. Current status and future directions. Invest. Radiol. 24, 1011-1016 (1989).
3. Langkowski J. H., Wieland J., Bomsdorf H., Leibfritz D., Westphal M., Offermann W. and Maas R. Pre-operative localized in vivo proton spectroscopy in cerebral tumors at 4.0 Tesla - first results. Magn. Reson. Imag. 7, 547-555 (1989).
4. Damaerel P., Johannik K., Van Hecke P., Van Ongeval C., Verellen S., Marchal G., Wilms G., Plets C., Goffin J., Van Calenbergh F., Lammens M. and Baert A. L. Localized 1H NMR spectroscopy in fifty new cases of newly diagnosed intracranial tumors. J. Cat. Asst. Tomogr. 15, 67-76 (1991).
5. Alger J. R., Frank J. A., Bizzi A., Fulham M. J., DeSouza B. X., Duhaney M. O., Inscoe S. W., Black J. L., van Zijl P. C. M., Moonen C. T. W. and Di Chiro G. Metabolism of human gliomas: Assessment with H-1 MR spectroscopy and F-18 flourodeoxyglucose PET. Radiology 177, 633-641 (1990).
6. Gill S. S., Thomas D. G., Van Bruggen N., Gadian D. G., Peden C. J., Bell J. D., Cox I. J., Menon D. K., Iles R. A. and Bryant D. J. Proton MR spectroscopy of intracranial tumors: in vivo and in vitro studies. J. Comput. Assist. Tomogr. 14, 497-504 (1990).
7. Kugel H., Heindel W., Ernestus R. I., Bunke J., du Mesnil R. and Friedman G. Human Brain Tumors: spectral patterns detected with localized H-1 MR spectroscopy. Radiology 183, 701-709 (1992).
8. Barker P. B., Glickson J. D. and Bryan R. N. In vivo magnetic resonance of human brain tumors. Topics Magn. Reson. Imag. 5, 32-45 (1993).
9. Chang L., McBride D., Miller B. L., Cornford M., Booth R. A., Buchthal S. D., Ernst T. M. and Jenden D. Localized in vivo 1H magnetic resonance spectroscopy and in vitro analyses of hetergeneous brain tumors. J. Neuroimag. 5, 157-163 (1995).
10. McBride D. Q., Miller B. L., Nikas D. L., Buchthal S., Chang L., Chiang F. and Booth R. A. Analysis of brain tumors using 1H magnetic resonance spectroscopy. Surgical Neurol. 44, 137-144 (1995).
11. Usenius J. P., Kauppinen R. A., Vaino P., Hernesniemi J. A., Vapalahti M. P., Paljarvi L. A. and Soimakallio S. Quantitative metabolite patterns of human brain tumors: detection by 1H NMR spectroscopy in vivo and in vitro. J. Comput. Assist. Tomogr. 18, 705-713 (1994).
12. Usenius J.-P., Vaino P., Hernesniemi J. and Kauppinen R. A. Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro. J Neurochem. 63, 1538-1543 (1994).
13. Negendank W. G., Sauter R., Brown T. R., Evelhoch J. L., Falini A., Gotsis E. D., Heerschap A., Kamada K., Lee B. C. and Mengeot M. M. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter trial. J. Neurosurg. 84, 449-458 (1996).
14. Sijens P. E., Kopp M. V., Brunetti A., Wicklow K., Alfano B., Bachert P., Sanders J. A., Stillman A. E., Kett H. and Sauter R. et al. 1H MR spectroscopy in patients with metastatic brain tumors: a multicenter study. Magn. Reson. Med. 33, 818-826 (1995).
15. Heesters M. A. A. M., Kamman R. L., Mooyaart E. L. and Go K. G. Localized proton spectroscopy of in operable brain tumuors. Response to radiation therapy. J. Neuro-Oncol. 17, 27-35 (1993).
16. Shimizu H., Kumabe T., Tominaga T., Kayama T., Hara K., Ono Y., Sato K., Arai N., Fujiwara S. and Yoshimoto T. Noninvasive Evaluation of Malignancy of Brain tumors with proton MR spectroscopy. Am. J. Neuroradiol. 17, 737-747 (1996).
17. Segebarth C. M., Baleriaux D. F., Luyten P. R. and den Hollander J. A. Detection of metabolic heterogeneity of human intracranial tumors in vivo by H-1 NMR spectroscopic imaging. Magn. Reson. Med. 13, 62-76 (1990).
18. Luyten P. R., Marien A. J., Heindel W., van G. P., Herholz K., den Hollander J., Friedman G. and Heiss W. D. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 176, 791-799 (1990).
19. Fulham M. J., Bizzi A., Dietz M. J., Shih H. H., Raman R., Sobering G. S., Frank J. A., Dwyer A. J., Alger J. R. and Di Chiro G. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 185, 675-686 (1992).
20. 11C]tyrosine positron emission tomography to localization of cerebral gliomas for biopsy. Neurosurgery 34, 994-1002 (1994).
21. Preul M. C., Caramanos Z., Collins D. L., Villemure J. G., Leblanc R., Olivier A., Pokrupa R. and Arnold D. L. Accurate non-invasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nature Med. 2, 323-325 (1996).
22. Simmons M. L., Frondoza C. G. and Coyle J. T. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45, 37-45 (1991).
23. Russell D. S. and Rubenstein Pathology of Tumors of the Nervous System, 5th Edn. Williams and Wilkins, London (1989).
24. Kleihues P., Burger P. C. and Scheithauer B. W. Histological Typing of Tumours of the Central Nervous System, 2nd Edn Springer, Berlin (1993).
25. Peeling J. and Sutherland G. High-resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn. Reson. Med. 24, 123-136 (1992).
26. Kinoshita Y., Kajiwara H., Yokota A. and Koga Y. Proton magnetic resonance spectroscopy of astrocytic tumors: an in vitro study. Neurol. Med. Chir. (Tokyo) 33, 350-9 (1993).
27. Kinoshita Y., Kajiwara H., Yokota A. and Koga Y. Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. Neurosurgery 35, 606-613 (1994).
28. Rutter A., Hugenholtz H., Saunders J. K. and Smith I. C. Classification of brain tumors by ex vivo 1H NMR Spectroscopy. J. Neurochem. 64, 1655-1661 (1995).
29. Somorjai R. L., Dolenko B., Nikulin A. K., Pizzi N., Scarth G., Zhilkin P., Halliday W., Fewer D., Hill N., Ross I., West M., Smith I. C. P., Donnelly S. M., Kuesel A. C. and Briere K. M. Classification of 1H MR spectra of human brain neoplasms: The influence of preprocessing and computerized consensus diagnosis on classification accuracy. J. Magn. Reson. Imag. 6, 437-444 (1996).
30. Prados M. D. Treatment strategies for patients with recurrent brain tumors. Semin. Radiat. Oncol. 1, 62-68 (1991).
31. Nelson D. F., Urtasun T. C., Saunders W. M., Gutin P. H. and Sheline G. E. Recent and current investigations of radiation therapy of malignant gliomas. Semin. Oncol. 13, 46-55 (1986).
32. Leibel S. A. and Sheline G. E. Radiation therapy for neoplasms of the brain. J. Neurosurg. 66, 1-22 (1987).
33. Leibel S. A., Scott C. B. and Loeffler J. S. Contemporary approaches to the treatment of malignant gliomas with radiation therapy. Semin. Oncol. 21, 198-219 (1994).
34. Wallner K. E., Galicich J. H., Krol G., Arbit E. and Malkin M. G. Patterns of failure following treatment for glioblastoma multi-forme and anaplastic astrocytoma. Int. J. Radiat. Oncol. Biol. Phys. 16, 1405-1409 (1989).
35. Walker M. D., Alexander Jr. E., Hunt W. E., MacCarty C. S., Mahaley Jr. M. S., Mealey Jr. J., Norell H. A., Owens G., Ransohoff J., Wilson C. B., Gehan E. A. and Strike T. A. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J. Neurosurg. 49, 333-343 (1978).
36. Walker M. D., Strike T. A. and Sheline G. E. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int. J. Radiat. Oncol. Biol. Phys. 5, 1725-1731 (1979).
37. Sheline G. E., Wara W. W. and Smith V. Therapeutic irradiation and brain injury. Int. J. Radiat. Oncol. Biol. Phys. 6, 1215-1228 (1980).
38. Gutin P. H., Phillips T. L., Hosobuchi Y., Wara W. M., MacKay A. M., Weaver K. A., Lamb S. and Hurst S. Permanent and removable implants for the brachytherapy of brain tumors. Int. J. Radiat. Oncol. Biol. Phys. 7, 1371-1381 (1981).
39. Larson D. A., Gutin P. H., Leibel S. A., Phillips T. L., Sneed P. K. and Wara W. M. Stereotaxic irradiation of brain tumors. Cancer 65, 792-799 (1990).
40. Leibel S. A., Gutin P. H., Wara W. M., Silver P. S., Larson D. A., Edwards M. S. B., Lamb S. A., Ham B., Weaver K. A., Barnett C. and Phillips T. L. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int. J. Radiat. Oncol. Biol. Phys. 17, 1129-1139 (1989).
41. Leibel S. A., Gutin P. H., Sneed P. K., Prados M. D., Levin K. J., Larson D. A., Wara W. M., Weaver K. A. and Phillips T. L. Interstitial irradiation for the treatment of primary and metastatic brain tumors. Principles Pract. Oncol. Update Series 3, 1-11 (1989).
42. Gutin P. H., Prados M. D., Phillips T. L., Wara W. M., Larson D. A., Leibel S. A., Sneed P. K., Levin V. A., Weaver K. A., Silver P., Lamborn K., Lamb S. and Ham B. External irradiation followed by an interstitial high activity iodine-125 implant boost in the initial treatment of malignant gliomas: NCOG study 6G-82-2, Int. J. Radiat. Oncol. Biol. Phy. 21, 601-606, 1991.
43. Posner J. B. Brain Metastases: A Clinician's View. In Brain Metastases, ed. by L. Weiss, H. A. Gilbert and J. B. Posner, pp. 2-29. G. K. Hill, Boston (1980).
44. Boring C. C., Squires T. S. and Tong R. Cancer Statistics, 1992, Clime. Abst. 1992; 42, 19-38.
45. Lang E. F. and Slater J. Metastatic brain tumors. Results of surgical and non-surgical treatment. Surg. Clin, North Am. 44, 865-872; 1964.
46. Markesbery W. R., Brooks W. H., Gupta G. D. and Young A. B. Treatment for patients with cerebral metastases. Arch. Neurol. 35, 754-756; 1978.
47. Richards P. and McKissock W. Intracranial metastases. Br. Med. J. 1, 15018, 1963.
48. Chao J. H., Phillips R. and Nickson J. J. Roentgen-ray therapy of cerebral metastases. Cancer 1954; 7, 682-680.
49. Chu F. C. H. and Hilaris B. B. Value of radiation therapy in the managnement of intracranial metastases. Cancer 1961; 14, 577-581.
50. Zimm S., Wampler G. L., Stablein D., Hazra T. and Young H. F. Intracerebral metastases in solid tumor patients: naturel history and results of treatment. Cancer 48, 384-394; 1981.
51. Flickinger J. C., Kondziolka D., Lunsford L. D., Coffey R. J., Goodman M. L. and Shaw E. G. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastases. Int. J. Radial. Oncol. Biol. Phys. 1994; 22, 797-802.
52. Mehta M. P., Rozental J. M., Levin A. B., Mackie T. R., Kubsad S. S., Gehring M. A. and Kinsella T. J. Defining the role of radiosurgery in the managnement of brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 1992; 24, 619-625.
53. Moriarty T. M., Loeffler J. S., Black P. M., Shrieve D. C., Wen P. Y., Fine H. A., Kooy H. M. and Alexander E. Long term follow-up of patients treated with stereotactic radiosurgery for single or multiple brian metastases: In Radiosurgery, Vol 1, ed. by D. Kondziolka, pp. 83-91. Karger, Basel (1995).
54. Alder J. R., Cox R. S., Kaplan I. and Martin D. P. Stereotactic radiosurgical treatment of brain metastases. J. Neurosurg. 76, 444-449, 1992.
55. Engenhart R., Kimmig B. N., Hover K. H., Bernd W., Romahn J. and Lorenz W. J. et al. Long term follow-up for brain metastases treated by percutaneous stereotactic single high dose irradiation. Cancer 1993; 71, 1353-1561.
56. Kihlstrom L., Karlsson B. and Lindquist C. Gamma knife radiosurgery for cerebral metastases. Implications for survival based upon 16 years experience. Stereotact. Funct. Neurosurg. 1993; 61, 45-50.
57. Shiau C.-Y., Sneed P. K., Shu H.-K., Nowak P., McDermott M. W., Lamborn K. R., Change S., Ho M., Park E., Petti P. L., Smith V., Verhey L. J., Wara W. M., Gutin P. H. and Larson D. A. Radiosurgery for brain metastases: relationship of initial radiographic pattern of enhancement and radiosurgery dose on local control. Int. J. Radiat. Oncol. Biol. Phys. 37, 375-383 (1997).
58. Sneed P. K., Lamborn K. L., Forstner J.-M., McDermott M. W., Hange S., Park E., Gutin P. H., Phillips T. L., Wara W. M. and Larson D. A. Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int. Radiat. Oncol. Biol. Phys. 43, 549-558 (1999).
59. Vogl T. J., Friebe C. E., Balzer T., Mack M. G., Steiner S., Schedel H., Pegios W., Lanksch W., Banzer D. and Felix R. Diagnosis of cerebral metastasis with standard dose gadobutrol vs. a high dose protocol. Intraindividual evaluation of a phase II high dose study, Radiologe, 35, 508-16, 1995.
60. Yuh W. T., Nguyen H. D., Tali E. T., Mayr N. A., Fisher D. J., Atlas S. W., Carvlin M. C., Drayer B. P., Pollei S. R. and Runge V. M. Delineation of gliomas with various doses of MR contrast material. Am. Neuroradol. 15(5): 983-9, 1994.
61. Kurki T., Lundbom N., Kalimo H. and Valtonen S. MR classification of brain gliomas: value of magnetization transfer and conventional imaging, Magn. Reson. Imag. 13, 501-11, 1995.
62. Rydberg J. N., Hammond C. A., Grimm R. C., Erickson B. J., Jack Jr. C. R., Huston 3rd J. and Riederer S. J. Initial clinical experience in MR imaging of the brain with a fast fluid-attenuated inversion-recovery pulse sequence, Radiology 193, 173-80, 1994.
63. De Coene B., Hajnal J. V., Gatehouse P., Longmore D. B., White S. J., Oatridge A., Pennock J. M., Young I. R. and Bydder G. M. MR of the brain using fluid-attenuated inversion recovery (FLAIR) pulse sequences. Am. J. Neuroradiol. 13, 1555-64, 1992.
64. Bruhn H., Frahm J., Gyngell M. L., Merboldt K. D., Hanicke W., Sauter R. and Hamburger C. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 1989; 172, 541-8.
65. Nelson S. J., Huhn S., Vigneron D. B., Day M. R., Wald L. L., Prados M., Chang S., Gutin P., Sneed P. K., Verhey L., Hawkins and Dillon W. P. Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors. Magn. Reson. Imag. 7: 146-1152, 1997.
66. Wald L. L., Moyher S. E., Day M. R., Nelson S. J. and Vigneron D. B. Proton spectroscopic imaging of the human brain using phased array detectors, Magn. Reson. Med. 34, 440-445, 1995.
67. Spielman D. M., Pauly J. M., Macovski A., Glover G. H. and Enzmann D. R. Lipid-suppressed single-and multisection proton spectroscopic imaging of the human brain. Magn. Reson. Imag. 1992; 2(3), 253-62.
68. Duyn J. H., Gillen J., Sobering G., van Zijl P. C. and Moonen C. T. Multisection proton MR spectroscopic imaging of the brain. Radiology 1993; 188(1), 277-82.
69. Duyn J. and Moonen C. T. W. Fast proton spectroscopic imaging of human brain using multiple spin echos, Magn. Reson. Med. 30, 409-414 (1993).
70. Adelsteinsson E., Irarrazabal P., Spielman D. M. and Macovski A. Three-dimensional spectroscopic imaging with time-varying gradients, Magn. Reson. Med. 33, 461-466, 1995.
71. Posse S., Tedeschi G., Risinger R., Ogg R. and Le Bihan D. High Speed 1H spectroscopic imaging in human brain by echo planar spatial-spectral encoding, Magn. Reson. Med. 33, 34-40, 1995.
72. Posse S., DeCharli C. and Bihan D. L. Three-dimensional echoplanar MR spectroscopic imaging at short echo times in the human brain. Radiology 192, 733-733 (1994).
73. Laue E. D., Skilling J., Staunton J., Sibisi S. and Bretereton R. G. Maximum entropy method in NMR spectroscopy. J. Magn. Reson. 62, 437-452 (1985).
74. Barkhuijsen H., de Beer R., Bovee W. M. M. J. and van Ormondt D. Retrieval of frequencies, amplitudes, damping factors and phases from time domain data signal using a linear least-squares procedure. J. Magn. Reson. 61, 465-481 (1985).
75. 31P NMR signals using the variable projection method and prior knowledge, Magn. Res. Med. 6, 92-98, 1988.
76. Derby K., Hawryszko H. and Tropp J. Baseline deconvolution, phase correction and signal quantification in Fourier localized spectroscopic imaging, Magn. Reson. Med. 12, 235-240, 1989.
77. Nelson S. J. and Brown T. R. A new method for automatic quantification of 1-D spectra with low signal to noise ratio. J. Magn. Reson. 75, 229-243, 1987.
78. Nelson S. J. and Brown T. R. A study of the accuracy of quantification which can be obtained from 1-D NMR spectra using the PIQABLE algorithm. J. Magn. Reson. 84, 95-109, 1989.
79. Nelson S. J. and Brown T. R. Peak detection and quantification in NMR spectra using the PIQABLE algorithm. Bull. Magn. Reson. 11, 127-130, 1990.
80. Spielman D., Webb P. and Macovski A. Water referencing for spectroscopic imaging. Magn. Reson. Med. 12, 38-49, 1989.
81. Spielman D., Webb P. and Macovski A. A Statistical Framework for in vivo spectroscopic imaging, J. Magn. Reson. 79, 66-77, 1988.
82. Nelson S. J., Vigneron D. B. and Brown T. R. Detection of significant features and analysis of 2D and 3D images of 31P metabolites. Magn. Reson. Med., 25, 85-93, 1992.
83. 1H spectroscopic imaging of human brain. Magn. Reson. Imag. 10, 315-319, 1992.
84. Nelson S. J., Nalbandian A. B. and Vigneron D. B. Registration of images from sequential MR examinations of the brain. J. Magn. Reson. Imag. 6, 877-883, 1994.
85. Moyher S. E., Vigneron D. B. and Nelson S. J. Surface Coil MRI of the human brain with an analytical reception profile correction. Magn. Reson. Imag. 7, 512-517, 1997.
86. Nelson S. J., Vigneron D. B. and Kelley D. A. C. Segmentation of contrast enhancing tumor and edematous tissue from grey matter, white matter and CSF using multiple volume MR images. Society of Magnetic Resonance in Medicine Annual Meeting, p. 4207, (1992).
87. Cline H. E., Kikinis R. and Jolesz F. Three dimensional segmentation of MR images of the head using probability theory and connectivity, J. Comput. Assist. Tomogr. 14, 1037-1045, 1990.
88. Lim K. O. and Pfefferbaum A. Segmentation of brain MR images into cerebrospinal fluid spaces, white and gray matter, J. Comput. Assist. Tomogr. 13, 588-593, 1989.
89. Hohne K. H. and Hanson W. A. Interactive sgegmentation of MRI and CT volumes using morphological operations. J. Comput. Assist. Tomogr. 16, 285-294, 1992.
90. Cline H. E., Dumolin C. L., Hart H. R., Lorenson W. E. and Ludke S. 3D reconstruction of the brain from magnetic resonance images using a connectivity algorithm. Magn. Reson. Imag. 5, 345-352, 1987.
91. Vigneron D. B., Wald L. L., Day M. R., Moyher S. E., Henry R. G., Dillon W. P. and Nelson S. J. 3D MR spectroscopic imaging of brain tumors: correlations with histology. Soc. Magn. Reson. Med. Annual Meeting, p. 975, New York (1996).
92. Wald A. A., Day M. R., Nelson S. J., Moyher S. E., Henry R. G., Sneed P. K., Huhn S. L., Chang S., Prados M. D., Dillon W. P., Gutin P. H., McDermott M. and Vigneron D. B. Response of glioblastoma multiforme to brachytherapy detected by 3D proton magnetic resonance spectroscopic imaging. J. Neurosurg. 87, 525-534, 1997.
93. Nelson S. J., Day M. R., Henry R. G., Wald L. L., Noworolski S. M., Star-Lack J. M., Dillon W. P. and Vigneron D. B. Differences between anatomic and metabolic abnormalities associated with primary brain tumors as assessed by Gadolinium enhanced MRI and 3D Proton MR Spectroscopic Imaging, Society of Magnetic Resonance in Medicine, 5th Annual Meeting, p. 1112 (1997).
94. Brem S., Colran R. and Folkman J. Tumor Angiogenesis: A quantiative method for histologic grading. J. Natl Cancer Inst. 48, 347-356, 1972.
95. Macchiarini P., Fontanini G. and Hardin M. Relation of neovascularization to metastases of non-small-cell lung cancer. Lancet 340, 145-6, 1992.
96. Black P. Brain tumors. N. Engl. J. Med. 324, 1471-1476, 1991.
97. Fisel C. R., Ackerman J. L., Buxton R. B., Garrido L., Belliveau J. W., Rosen B. R. and Brady T. J. MR contrast due to microscopically heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn. Reson. Med. 17, 336-347 (1991).
98. Rosen B. R., Belliveau J. W. and Chien D. Perfusion imaging by nuclear magnetic resonance, Magn. Reson. Quart. 5, 263-281, (1989).
99. Edelman R. R., Mattle H. P., Atkinson D. J., Hill T., Finn J. P., Mayman C., Ronthal M., Hoogewoud H. M. and Kleefield J. Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR Imaging at 1.5 T, Radiology 176, 211-220 (1990).
100. Weisskoff R. M., Boxerman J. L., Sorensen A. G., Kulke S. M., Campbell T. A. and Rosen B. R. Silmultaneous blood volume and permeability mapping using a single Gd-based contrast injection. Soc. Magn. Reson. Med. Abstracts, 1994.
101. Kennan R. P., Zhong J. and Gore J. C. Intravascular susceptibility contrast mechanisms in tissues. Magn. Reson. Med. 31,9-21 (1994).
102. Larson K. B., Perman W. H., Perlmutter J. S., Gado M. H., Ollinger J. M. and Zierler K. Tracer-kinetic analysis for measuring regional cerebral blood flow by dynamic nuclear magnetic resonance imaging, J. Theor. Biol. 170, 1-14 (1994).
103. Aronen H. J., Gazit I. E., Louis D. N., Buchbinder B. R., Pardo F. S., Weisskoff R. M., Harsh G. R., Cosgrove C. R., Halpern E. F., Hochberg F. H. and Rosen B. R. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings, Radiology 191,41-51 (1994).
104. Pardo F. S., Aronen H. J., Kennedy D., Moulton G., Paiva K., Okunieff P., Schmidt E. V., Hochberg F. H., Harsh G. R., Fischman A. J., Linggood R. M. and Rosen B. R. Functional cerebral imaging in the evaluation and radiotherapeutic treatment planning of patients with malignant glioma, Int. J. Radiat. Oncol. Biol. Phys. 30(3), 663-9 (1994).
105. Wenz F., Rempp K., Brix G., Hess T., Weisser G., Debus J., Knopp M. V., Engenhart R. and van Kaick G. Radiation induced rCBV changes of low grade astrocytomas and normal brain tissue, Soc. Magn. Reson. Med. Abstracts, 1994.
106. Maeda M., Itoh S., Kimura H., Iwasaki T., Hayashi N., Yamamoto K., Ishii Y. and Kubota T. Tumor vasularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging, Radiology 189, 233-238 1993.
107. Guckel F., Brix G., Rempp K., Deimling M., Rother J. and Georgi M. Assessment of cerebral blood volume with dynamic susceptibility contrast enhanced gradient-echo imaging, J. Comput. Assist. Tomogr. 18(3), 344-351, 1994.
108. Perman W. H., Mokhtar H. G., Larson K. B. and Perlmutter J. S. Simultaneous MR acquisition of arterial and brain signal-time curves, Magn. Reson. Med. 28, 74-83 (1992).
109. Henry R. G., Vigneron D. B., Fischbein N., Grant P. E., Day M. R., Noworolski S. M., StarLack J. M., Dillon W. P., Chang S. and Nelson S. J. Comparison of proton MRSI and cerebral blood volume imaging of gliomas, International Society of Magnetic Resonance in Medicine 5th Annual Meeting, p. 1123 (1997).
110. 18F) Fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. Ann. Neurol. 33, 540-548, 1993.
111. 18F fluorodeoxyglucose positron emission tomography. Ann. Neurol. 29, 347-355, 1991.
112. Lilja A., Lundqvist H. and Olsson Y. et al. Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions. Acta Radiol. 30, 121-128, 1989.
113. Patronas N., di Chiro G. and Kufta C. et al. Prediction of Survival in glioma patients by means of positron emission tomography. J. Neurosurg. 62, 816-822, 1985.
114. Di Chiro G. Positron emission tomography using F-18-fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool, Invest. Radiol. 1986, 22, 360-371.
115. Kim 6. E. E., Chung S. K., Haynie T. P., Kim C. G., Cho B. J., Podoloff D. A., Tilbury R. S., Yang D. J., Yung W. K. and Moser Jr. R. P. et al. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. Radiographics. 1992 12, 269-79.
116. Day M. R., Vigneron D. B., Wald L. L., Huhn S. L., Chang S., Hawkins R. M., Dillon W. P. and Nelson S. J. Comparison of 3D proton MR spectroscopy and high resolution F-18 fluorodeoxyglucose PET for patients with recurrent brain tumors. Proceedings of the Annual Meeting of the American Society of Neuroradiology. p. 35 (1996).
117. Nelson S. J., Day M. R., Buffone P., Wald L. L., Budinger T. F., Hawkins R., Dillon W., Huhn S., Prados M., Chang S. and Vigneron D. B. Registration of Volume MRI and High Resolution F-18 Flurodeoxyglucose PET Images for Evaluation of Patients with Brain Tumors. J. Comput. Assist. Tomors, 21, 183-191, 1996.
118. Nelson S. J., Vigneron D. B., Day M. R., Henry R. G., McDermott M., Gutin P. H., Larson D. A., Sneed P. K., Verhey L., Prados M. D., Chang S. and Dillon W. Assessment Of Response To Radiosurgery For Patients With Metastatic Brain Tumors Using MR Imaging And Proton MR Spectroscopic Imaging, Am. J. Neuro. Radiol. (in press).
119. Day M. R., Nelson S. J., Henry R. G., Moyher S. E., Partridge S., Star-Lack J. M., Vigneron D. B. and Dillon W. P. Assessment of Response to Gamma Knife Radiosurgery for Patients with Malignant Gliomas using Serial MRSI, International Society of Magnetic Resonance in Medicine, 5th Annual Meeting, p. 20 (1997).